HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasmacytoid adenocarcinoma of the lung.

Abstract
Plasmacytoid adenocarcinoma of the lung has not been reported. Herein reported is the first case of plasmacytoid adenocarcinoma of the lung. A 68-year-old man presented with cough and sputum. X-P and CT demonstrated a large tumor (10 x 10 x 9 cm) in the right upper lobe. CT-guided needle biopsy was performed. The biopsy showed plasmacytoid malignant cells. The malignant cells were small, had eccentrically located nuclei, perinuclear halo, and basophilic cytoplasm. No mucins were observed by mucins stains. Immunohistochemical study showed that the tumor cells were positive for pancytokeratin AE1/3, pancytokeratin CAM5.2, TTF-1, Ki-67 (labeling 70%), CA19-9, and p53. They were negative for neuron specific enolase, CEA, CD45, CD68, chromogranin, synaptophysin, surfactant apoprotein A, CDX-2, κ-chain, λ-chain, KIT, and PDGFRA. Since epithelial markers and adenocarcinoma markers were positive, the pathological diagnosis was plasmacytoid adenocarcinoma of lung. The patient is now treated with chemotherapy.
AuthorsTadashi Terada
JournalInternational journal of clinical and experimental pathology (Int J Clin Exp Pathol) Vol. 5 Issue 4 Pg. 356-8 ( 2012) ISSN: 1936-2625 [Electronic] United States
PMID22670180 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Biomarkers, Tumor
Topics
  • Adenocarcinoma (chemistry, drug therapy, pathology)
  • Adenocarcinoma of Lung
  • Aged
  • Biomarkers, Tumor (analysis)
  • Biopsy, Needle
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms (chemistry, drug therapy, pathology)
  • Male
  • Plasma Cells (chemistry, drug effects, pathology)
  • Predictive Value of Tests
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: